| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 32.58× | 32.58× | 32.12× | 39.62× | 34.52× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.91× | 1.70× | 1.11× | 1.47× | 0.60× | ||
| 0.41× | 0.41× | 0.30× | 0.18× | 0.13× | ||
| 1.25× | 1.25× | 0.31× | 3.68× | −0.67× | ||
| 1.01× | 1.01× | 0.27× | 7.11× | −0.69× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 34.52 | 39.62 | 32.12 | 32.58 | 32.58 | |
| Working Capital Turnover | 0.60 | 1.47 | 1.11 | 1.70 | 1.91 | |
| Asset Turnover | 0.13 | 0.18 | 0.30 | 0.41 | 0.41 | |
| Cash Conversion (CFO/Net Income) | -0.67 | 3.68 | 0.31 | 1.25 | 1.25 | |
| CFO/EBITDA | -0.69 | 7.11 | 0.27 | 1.01 | 1.01 |